Does Mounjaro Work for Everyone? UK Expert Guide 2025

Clinically Proven UK Registered Pharmacy

Does Mounjaro Work for Everyone - Cheapest UK Price

Find out if Mounjaro is right for you and get the cheapest UK price from £124.99 plus £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £124.99 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation

Does Mounjaro Work for Everyone? Understanding Individual Response

If you're asking does Mounjaro work for everyone UK, the short answer is no — but understanding why helps you maximise your chances of success. Mounjaro (tirzepatide) delivers significant weight loss in clinical trials, yet individual response varies based on metabolic factors, adherence, and lifestyle integration. At Cured Pharmacy, our UK-registered clinical team helps patients optimise outcomes through personalised prescribing and evidence-based guidance.

Does Mounjaro Work for Everyone? What Clinical Trials Tell Us

In the landmark SURMOUNT-1 trial, 91% of participants achieved at least 5% body weight reduction on the highest tirzepatide dose, with an average loss of 22.5% over 72 weeks [1]. This represents one of the highest response rates ever recorded for a weight management medication approved by the MHRA.

However, individual results varied considerably. While some patients lost over 30% of their starting weight, approximately 9% did not reach the 5% threshold considered clinically meaningful [1]. Response depends on baseline metabolic health, insulin resistance severity, adherence to dosing schedules, and concurrent lifestyle modifications.

The SURMOUNT-3 trial demonstrated that patients who completed the full dose escalation protocol and maintained consistent weekly injections achieved significantly better outcomes than those with interrupted treatment [2]. This highlights that Mounjaro effectiveness is not solely about the medication itself — it requires active patient engagement and clinical support throughout the treatment journey.

Who Responds Best to Mounjaro Treatment?

Clinical evidence suggests certain patient profiles achieve superior outcomes with tirzepatide therapy. Those with higher baseline insulin resistance, prediabetes, or type 2 diabetes often experience greater weight loss due to Mounjaro's dual GIP/GLP-1 mechanism targeting both glucose metabolism and appetite regulation [1][3].

Patients who begin treatment with a BMI above 35 kg/m² typically see more substantial absolute weight reduction, though percentage losses remain consistent across BMI categories. Younger patients and those without significant metabolic complications may experience slower initial response but often achieve excellent long-term results with consistent adherence.

Your UK prescriber will assess your metabolic profile, weight loss history, and concurrent medications during your clinical consultation to determine if Mounjaro represents the optimal choice for your individual circumstances. Subject to prescriber approval, treatment starts at the lowest dose and escalates gradually to maximise tolerance and effectiveness.

Factors That Predict Better Mounjaro Response

Research identifies several predictive factors for enhanced tirzepatide outcomes: higher baseline HbA1c levels, elevated fasting insulin, history of difficulty losing weight with diet alone, and absence of prior bariatric surgery [2][3]. Patients with these characteristics often achieve weight loss exceeding trial averages when combined with structured dietary support and regular physical activity.

Why Some Patients Don't Respond to Mounjaro

Approximately 9-15% of patients do not achieve clinically meaningful weight loss on Mounjaro, defined as less than 5% body weight reduction after 6 months at the maintenance dose [1][2]. Non-response stems from several mechanisms: genetic variations in GLP-1 receptor sensitivity, pre-existing gastroparesis that limits tolerability, or metabolic adaptations from previous weight cycling.

Inadequate dose escalation represents another common cause of suboptimal response. Patients who remain on lower doses due to side effect concerns or prescriber caution may not reach the therapeutic threshold required for significant weight loss. The SURMOUNT trials demonstrated clear dose-response relationships, with the 15mg weekly dose producing substantially greater effects than the 5mg or 10mg doses [1].

Medication interactions can also blunt Mounjaro's effectiveness. Certain psychiatric medications, corticosteroids, and hormonal therapies may counteract weight loss effects. Your UK prescriber reviews your complete medication list during consultation to identify potential interactions and adjust treatment accordingly.

When to Consider Alternative Weight Loss Treatments

If you experience intolerable side effects during dose escalation or fail to achieve 5% weight loss after 6 months at the maximum tolerated dose, your prescriber may recommend switching to alternative therapies. Wegovy (semaglutide) offers a single-pathway GLP-1 approach that some patients tolerate better, whilst Saxenda's daily dosing provides more flexible titration for those sensitive to weekly injections. Orlistat-based treatments like Xenical work through an entirely different mechanism — blocking dietary fat absorption rather than affecting appetite hormones — and may suit patients who cannot tolerate GLP-1 receptor agonists.

Treatment Active Ingredient Average Weight Loss Dosing Frequency Starting Price
Mounjaro Tirzepatide 15-22.5% over 72 weeks Once weekly injection From £124.99
Wegovy Semaglutide 12-15% over 68 weeks Once weekly injection From £69.00
Saxenda Liraglutide 8-9% over 56 weeks Daily injection From £68.00
Xenical Orlistat 120mg 3-5% over 12 months Three times daily oral From £32.00
Orlistat Generic Orlistat 120mg 3-5% over 12 months Three times daily oral From £32.00

Expert Tips to Maximise Your Mounjaro Results

Optimising Mounjaro outcomes requires strategic integration of medication with evidence-based lifestyle modifications. Clinical data shows patients who combine tirzepatide with structured dietary counselling achieve 3-5% greater weight loss than those relying on medication alone [2]. Focus on protein intake of at least 1.2g per kilogram of body weight daily to preserve lean muscle mass during rapid weight loss.

Timing your injection consistently each week — ideally on the same day and at the same time — maintains stable drug levels and reduces breakthrough hunger between doses. Many patients find injecting in the evening minimises nausea, as peak drug concentration occurs during sleep when symptoms are less noticeable.

Hydration plays a crucial role in managing common side effects and supporting metabolic function. Aim for 2-3 litres of water daily, increasing intake during hot weather or exercise. Adequate hydration reduces constipation risk, supports kidney function during rapid weight loss, and helps distinguish true hunger from thirst signals.

Managing Side Effects to Stay on Treatment

The most common reason patients discontinue Mounjaro prematurely is gastrointestinal side effects — particularly nausea, which affects up to 30% of users during dose escalation [1]. Eating smaller, more frequent meals rather than three large portions significantly reduces nausea severity. Avoid high-fat foods, which delay gastric emptying and exacerbate GI symptoms. If nausea persists beyond the first month at a new dose, consult your prescriber about extending the escalation timeline or trying anti-nausea strategies before increasing further.

Mounjaro Success Rates Compared to Other UK Weight Loss Treatments

Head-to-head comparisons demonstrate tirzepatide's superior efficacy profile within the GLP-1 medication class. In the SURPASS-2 trial, patients on Mounjaro 15mg achieved 12.4kg average weight loss compared to 6.2kg with semaglutide 1mg over 40 weeks — double the effect despite semaglutide itself being highly effective [4].

Compared to oral treatments like Orlistat, which typically produces 3-5% weight loss, Mounjaro's 15-22.5% average reduction represents a step-change in pharmacological weight management [1][5]. However, Orlistat-based treatments like Xenical or Alli remain valuable options for patients who cannot tolerate injectable therapies or prefer oral medication.

Liraglutide (Saxenda) offers daily injection dosing that some patients find easier to integrate into their routines, though clinical trials show average weight loss of 8-9% — approximately half that achieved with tirzepatide at maximum doses [3][4]. Your UK prescriber considers these comparative efficacy profiles alongside your individual preferences, medical history, and tolerability concerns when recommending the most appropriate treatment.

Getting Started with Mounjaro at Cured Pharmacy

At Cured Pharmacy, Mounjaro is available from £124.99 following a free online consultation with our UK-registered prescribers. Your assessment takes under 3 minutes and covers your medical history, current medications, weight loss goals, and any contraindications to GLP-1 therapy.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team provide ongoing support throughout your treatment journey, including dose escalation guidance, side effect management, and lifestyle optimisation strategies. All Mounjaro pens are genuine UK-licensed medications sourced directly from licensed wholesalers and dispensed from our GPhC-registered pharmacy (9012511).

We offer discreet packaging and flexible delivery options across the UK. Transparent upfront pricing means you see the exact cost before completing your consultation — no hidden fees or surprise charges. If your prescriber determines Mounjaro is not suitable for your individual circumstances, they may recommend alternative treatments like Wegovy, Saxenda, or Orlistat-based options, all available through the same streamlined consultation process.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
  2. Wadden, T. A., Chao, A. M., Machineni, S., et al. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 randomised trial. The Lancet, 402(10405), 957–969. https://doi.org/10.1016/S0140-6736(23)01199-9
  3. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0
  4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
  5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss outcomes depend on adherence, lifestyle factors, and individual metabolic response.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Does Mounjaro work for everyone trying to lose weight?
No. While 91% of patients in clinical trials achieved at least 5% weight loss, approximately 9% did not reach this threshold. Individual response depends on metabolic factors, adherence, and lifestyle integration. Your UK prescriber assesses your suitability during consultation.
How long does it take to see if Mounjaro is working for you?
Most patients notice appetite reduction within 1-2 weeks of starting treatment, with measurable weight loss evident by week 4-6. Clinical guidelines recommend assessing response after 6 months at the maintenance dose — if you haven't achieved 5% weight loss by then, alternative treatments may be more suitable.
Why do some people lose more weight on Mounjaro than others?
Individual response varies based on baseline insulin resistance, genetic factors affecting GLP-1 receptor sensitivity, adherence to dosing schedules, concurrent lifestyle modifications, and metabolic adaptations from previous weight loss attempts. Higher baseline BMI and insulin resistance often predict greater absolute weight loss.
Can you improve your results if Mounjaro isn't working well initially?
Yes. Extending the dose escalation timeline, optimising injection timing, increasing protein intake, addressing hydration, and working with a dietitian can enhance response. If results remain suboptimal after 6 months at maximum tolerated dose, your prescriber may recommend switching to alternative therapies like Wegovy or Saxenda.
What percentage of patients stop Mounjaro due to side effects?
In clinical trials, approximately 6-8% of participants discontinued tirzepatide due to adverse effects, primarily gastrointestinal symptoms like nausea and vomiting. Most side effects resolve within 4-6 weeks as your body adapts to each new dose level.
Does Mounjaro work better for people with diabetes?
Patients with type 2 diabetes or prediabetes often experience greater weight loss due to Mounjaro's dual mechanism targeting both glucose metabolism and appetite regulation. However, the medication remains highly effective for weight management in people without diabetes, as demonstrated in the SURMOUNT trials specifically designed for obesity treatment.
Is Mounjaro more effective than Wegovy for weight loss?
Yes, on average. Head-to-head trials show tirzepatide produces approximately double the weight loss of semaglutide at comparable timepoints — 12.4kg versus 6.2kg over 40 weeks in SURPASS-2. However, individual response varies, and some patients tolerate or respond better to Wegovy's single-pathway GLP-1 mechanism.
Who should not take Mounjaro for weight loss?
Mounjaro is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastroparesis, or known hypersensitivity to tirzepatide. Your UK prescriber reviews your complete medical history during consultation to determine suitability and identify any contraindications.
Does Mounjaro work for everyone who tries it in the UK?
Mounjaro doesn't work equally for everyone, as individual response varies based on factors like metabolism, adherence, and underlying health conditions. Clinical trials show approximately 89% of patients achieve clinically significant weight loss, though results differ. Cured Pharmacy's prescribers assess your suitability during consultation to maximise your chances of success.
Why doesn't Mounjaro work for some people in the UK?
Mounjaro may not work effectively if patients don't follow dosing schedules, fail to make lifestyle changes, or have certain metabolic conditions affecting drug response. Genetic factors and medication interactions can also reduce effectiveness. Cured Pharmacy provides ongoing support and dose adjustments to help optimise your treatment outcomes.
How long before I know if Mounjaro will work for me?
Most people see initial weight loss within 4-8 weeks on Mounjaro, with more significant results appearing after 12-16 weeks. If you haven't lost at least 5% body weight after 16 weeks at therapeutic dose, your prescriber may reassess your treatment. Cured Pharmacy offers regular check-ins to monitor your progress and adjust your plan accordingly.
Can I switch from Wegovy to Mounjaro if one doesn't work?
Yes, switching between GLP-1 treatments like Wegovy and Mounjaro is possible if one doesn't deliver expected results, as they work through slightly different mechanisms. Your prescriber will guide the transition with appropriate dose mapping and washout periods. Cured Pharmacy can facilitate switches between weight loss medications based on your individual response and clinical needs.
Is Mounjaro more effective than other weight loss medications available in the UK?
Clinical studies show Mounjaro (tirzepatide) typically produces greater weight loss than single-hormone treatments like Wegovy, with average losses of 15-20% versus 10-15% body weight. However, individual effectiveness varies, and the 'best' medication depends on your specific health profile and tolerance. Cured Pharmacy's prescribers help determine which treatment option suits you best based on medical assessment.
Does Mounjaro work for everyone who wants to lose weight?
Mounjaro is effective for most people with a BMI over 30 or over 27 with weight-related health conditions, but individual results vary based on adherence, lifestyle changes, and metabolic factors. Clinical trials show around 90% of users achieve significant weight loss, though some respond better than others. Cured Pharmacy offers UK-registered prescriber consultations to assess if Mounjaro is suitable for your specific circumstances.
Why doesn't Mounjaro work for everyone in clinical trials?
A small percentage of people may not respond to Mounjaro due to genetic variations affecting GLP-1 and GIP receptor sensitivity, medication interactions, or underlying metabolic conditions like insulin resistance. Poor adherence to dosing schedules, diet, and exercise also reduces effectiveness. If Mounjaro doesn't work for you after several months, Cured Pharmacy can help review your treatment plan with a UK prescriber.
How can I tell if Mounjaro is working for me?
Most people notice reduced appetite and weight loss within 4-8 weeks, with optimal results after 16-20 weeks as doses increase. If you've seen no weight loss or appetite changes after 12 weeks at therapeutic doses, Mounjaro may not be working effectively for you. Cured Pharmacy provides ongoing support to monitor your progress and adjust treatment if needed.
Can switching from Wegovy to Mounjaro help if Wegovy didn't work?
Yes, Mounjaro may work better for some people because it activates both GIP and GLP-1 receptors, while Wegovy only targets GLP-1. Some patients who plateau or don't respond to Wegovy see improved results with Mounjaro's dual-action mechanism. Cured Pharmacy can facilitate a safe switch with UK prescriber guidance and supply Mounjaro from £124.99.
Is Mounjaro more effective for certain BMI ranges in the UK?
Mounjaro shows high efficacy across BMI ranges over 27, but people with higher baseline BMIs (35+) often see greater absolute weight loss in kilograms, while those with lower BMIs may lose a higher percentage of body weight. Effectiveness depends more on adherence and metabolic health than BMI alone. Cured Pharmacy ensures you receive the right dose escalation for your weight loss goals regardless of starting BMI.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 17 July 2026